Wound related and lymphatic reflow-related complications are commonly seen in penile cancer patients after inguinal lymph node dissection (ILND). However, the risk factors for them remain unclear. The ...

Although initial data on laser therapy for the treatment of stress urinary incontinence (SUI) were encouraging, it now seems to be well established that the effectiveness of this modality for severe ...

Postoperative activity restrictions can affect patient satisfaction after midurethral sling (MUS) surgery. The aim of the study was to assess the effect of a duration of postoperative activity ...

To improve [177Lu]Lu-Prostate-specific membrane antigen therapy (LuPSMA) selection, this study investigates the prognostic value of PSMA and 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG)-PET in ...

To assess the incidence of acute kidney injury (AKI) and acute kidney disease (AKD) following radical cystectomy (RC) in patients with muscle-invasive bladder cancer (BCa). A consecutive cohort of 840 ...

High-resolution microultrasonography-guided biopsy is an alternative to MRI fusion-guided biopsy for prostate cancer diagnosis. To compare microultrasonography-guided and MRI fusion-guided biopsy. A ...

Initial management for overactive bladder includes behavioral modification with avoidance of bladder irritants. However, in 2017, the International Consultation on Incontinence concluded that more ...

This publication represents a summary of the updated 2025 European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). The aim is to provide practical ...

We present a summary of the 2025 update for the European Association of Urology (EAU) guidelines for upper urinary tract urothelial carcinoma (UTUC). The aim is to provide practical recommendations on ...

Overactive bladder (OAB) is a chronic disease with the symptoms of urgency with or without incontinence. Solifenacin is an antimuscarinic drug that Excels in OAB treatment due to its specific bladder ...

Neeraj Agarwal is joined by Alicia Morgans to discuss an analysis of baseline PSA levels and clinical outcomes from the ARASENS trial in metastatic hormone-sensitive prostate cancer. Dr. Morgans ...

Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong ...